Presentation is loading. Please wait.

Presentation is loading. Please wait.

Good Vibrations and the Power of Positron Thinking: Positron Emission Tomography and Endoscopic Ultrasound in Staging of Mesothelioma—Two Case Reports 

Published byうきえ かがんじ Modified over 5 years ago

Similar presentations

Presentation on theme: "Good Vibrations and the Power of Positron Thinking: Positron Emission Tomography and Endoscopic Ultrasound in Staging of Mesothelioma—Two Case Reports "— Presentation transcript:

1 Good Vibrations and the Power of Positron Thinking: Positron Emission Tomography and Endoscopic Ultrasound in Staging of Mesothelioma—Two Case Reports  Craig P. Carden, MBBS, FRACP, James S. Myerson, MBBS, BSc, MRCP, Sanjay Popat, MBBS, BSc, PhD, MRCP, Ana Montes, MBBS, PhD, James M.G. Larkin, MA, PhD, MRCP, Martin J. Benson, MBBS, MRCP, Mary E.R. O'Brien, MD, FRCP  Journal of Thoracic Oncology  Volume 3, Issue 5, Pages (May 2008) DOI: /JTO.0b013e31816fca34 Copyright © 2008 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 Case 1: Initial positron emission tomography (PET) showing uptake in region of esophagus (large arrow), and in pleural cavity (small arrows). Journal of Thoracic Oncology 2008 3, DOI: ( /JTO.0b013e31816fca34) Copyright © 2008 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Case 1: Computed tomography scan from 4 months after the positron emission tomography (PET) scan showing increasing size of esophageal lesion (white arrow). Journal of Thoracic Oncology 2008 3, DOI: ( /JTO.0b013e31816fca34) Copyright © 2008 International Association for the Study of Lung Cancer Terms and Conditions

4 FIGURE 3 Case 1: Computed Tomography scan from 7 months after initial positron emission tomography (PET) scan (Figure 1), showing enlargement of the esophageal mass, and esophageal stent in situ (black arrow). Journal of Thoracic Oncology 2008 3, DOI: ( /JTO.0b013e31816fca34) Copyright © 2008 International Association for the Study of Lung Cancer Terms and Conditions

5 FIGURE 4 Case 2: positron emission tomography (PET) scan after four cycles chemotherapy showing celiac node (white arrow). Journal of Thoracic Oncology 2008 3, DOI: ( /JTO.0b013e31816fca34) Copyright © 2008 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Good Vibrations and the Power of Positron Thinking: Positron Emission Tomography and Endoscopic Ultrasound in Staging of Mesothelioma—Two Case Reports "

Similar presentations

Endoscopic Ultrasound-Guided Fine Needle Aspiration of Mediastinal Lymph Node in Patients With Suspected Lung Cancer After Positron Emission Tomography.

Endoscopic Ultrasound-Guided Fine Needle Aspiration of Mediastinal Lymph Node in Patients With Suspected Lung Cancer After Positron Emission Tomography.
PET/CT Fusion Scan in Lung Cancer: Current Recommendations and Innovations  Cristina Gámez, MD, PhD, Rafael Rosell, MD, PhD, Alejandro Fernández, MD, PhD,

PET/CT Fusion Scan in Lung Cancer: Current Recommendations and Innovations  Cristina Gámez, MD, PhD, Rafael Rosell, MD, PhD, Alejandro Fernández, MD, PhD,
Rash in a Patient Treated with Pemetrexed for Relapsed Non-small Cell Lung Cancer  Isabelle Declercq, MD, Yolande Lievens, MD, PhD, Eric Verbeken, MD,

Rash in a Patient Treated with Pemetrexed for Relapsed Non-small Cell Lung Cancer  Isabelle Declercq, MD, Yolande Lievens, MD, PhD, Eric Verbeken, MD,
Paraneoplastic Opsoclonus-Myoclonus Syndrome as a New and Single Manifestation of Relapsing Disease in a Patient with Small Cell Lung Cancer  Ernest Nadal,

Paraneoplastic Opsoclonus-Myoclonus Syndrome as a New and Single Manifestation of Relapsing Disease in a Patient with Small Cell Lung Cancer  Ernest Nadal,
Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer

Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer
Utility of 18F-FDG PET for Predicting Histopathologic Response in Esophageal Carcinoma following Chemoradiation  Andrea L.H. Arnett, MD, PhD, Kenneth.

Utility of 18F-FDG PET for Predicting Histopathologic Response in Esophageal Carcinoma following Chemoradiation  Andrea L.H. Arnett, MD, PhD, Kenneth.
Response to Crizotinib Rechallenge after Initial Progression and Intervening Chemotherapy in ALK Lung Cancer  Eiko Theodora Browning, MD, Andrew James.

Response to Crizotinib Rechallenge after Initial Progression and Intervening Chemotherapy in ALK Lung Cancer  Eiko Theodora Browning, MD, Andrew James.
Paraneoplastic Limbic Encephalitis and Small-Cell Lung Carcinoma

Paraneoplastic Limbic Encephalitis and Small-Cell Lung Carcinoma
Jos A. Stigt, MD, PhD, Richard Vossenkaul, MD, Wouter H

Jos A. Stigt, MD, PhD, Richard Vossenkaul, MD, Wouter H
MET-Mutated NSCLC with Major Response to Crizotinib

MET-Mutated NSCLC with Major Response to Crizotinib
Resection of Mucinous Lung Adenocarcinoma Presenting with Intractable Bronchorrhea  Motoshi Takao, MD, PhD, Takehiro Takagi, MD, Hitoshi Suzuki, MD, PhD,

Resection of Mucinous Lung Adenocarcinoma Presenting with Intractable Bronchorrhea  Motoshi Takao, MD, PhD, Takehiro Takagi, MD, Hitoshi Suzuki, MD, PhD,
Predicting Radiation Esophagitis Using 18F-FDG PET During Chemoradiotherapy for Locally Advanced Non–Small Cell Lung Cancer  Qurrat Mehmood, MBChB., Alexander.

Predicting Radiation Esophagitis Using 18F-FDG PET During Chemoradiotherapy for Locally Advanced Non–Small Cell Lung Cancer  Qurrat Mehmood, MBChB., Alexander.
Electronic Updates for JTO Readers

Electronic Updates for JTO Readers
An Aortoesophageal Fistula in Patient with Lung Cancer after Chemo-Irradiation and Subsequent Esophageal Stent Implantation  Soo-Jung Um, MD, Byeong Ho.

An Aortoesophageal Fistula in Patient with Lung Cancer after Chemo-Irradiation and Subsequent Esophageal Stent Implantation  Soo-Jung Um, MD, Byeong Ho.
Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement– Positive Non–Small-Cell Lung Cancer  Hiroyasu Kaneda, MD, PhD, Isamu.

Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement– Positive Non–Small-Cell Lung Cancer  Hiroyasu Kaneda, MD, PhD, Isamu.
Lymph Node Ratio May Predict the Benefit of Postoperative Radiotherapy in Non– Small-Cell Lung Cancer  Damien Urban, MBBS, B Med Sc, Jair Bar, MD, PhD,

Lymph Node Ratio May Predict the Benefit of Postoperative Radiotherapy in Non– Small-Cell Lung Cancer  Damien Urban, MBBS, B Med Sc, Jair Bar, MD, PhD,
Successful Crizotinib Retreatment after Crizotinib-Induced Interstitial Lung Disease  Satoru Yanagisawa, MD, PhD, Akira Inoue, MD, PhD, Akira Koarai, MD,

Successful Crizotinib Retreatment after Crizotinib-Induced Interstitial Lung Disease  Satoru Yanagisawa, MD, PhD, Akira Inoue, MD, PhD, Akira Koarai, MD,
Tracheoesophageal Fistula Associated with Bevacizumab 21 Months after Completion of Radiation Therapy  Elizabeth Gore, MD, Adam Currey, MD, Nicholas Choong,

Tracheoesophageal Fistula Associated with Bevacizumab 21 Months after Completion of Radiation Therapy  Elizabeth Gore, MD, Adam Currey, MD, Nicholas Choong,
Early Response to Platinum-Based First-Line Chemotherapy in Non-small Cell Lung Cancer May Predict Survival  Bhawna Sirohi, MBBS, DCH, Sue Ashley, BSc,

Early Response to Platinum-Based First-Line Chemotherapy in Non-small Cell Lung Cancer May Predict Survival  Bhawna Sirohi, MBBS, DCH, Sue Ashley, BSc,
Primary Tracheal Lymphoma Causing Respiratory Failure

Primary Tracheal Lymphoma Causing Respiratory Failure

Similar presentations

Ads by Google